A diabetic patient with peripheral arterial disease
Diabetes mellitus and peripheral arterial disease frequently occur particularly at older age. Their simultaneous course presents a significant risk of vascular complications...
Authors: Tomáš Petrovič, Peter Jackuliak, Juraj Payer
Complex management of diabetic patients with lower extremity peripheral arterial disease
Extremitovascular arterial ischemic disease (lower extremity peripheral arterial disease – PAD) is an important manifestation of systemic atherosclerosis and other arterial...
Authors: Peter Gavorník, Andrej Dukát, Ľudovít Gašpar, Gabriela Gubo, Naďa Bežillová, Martina Kováčová, Eva Gavorníková, Anna Petrášová, Iveta Gašparová, Lujza Sabolová, Marek Kučera, Katarína Kusendová, Alena Uhrinová, Matej Bendžala, Dáša Mesárošová
PCSK9 inhibitors and the role of evolocumab in the therapy for patients with hyperlipoproteinemia
Relationship between LDL-cholesterol levels and cardiovascular risk is clear nowadays in the evidence-based medicine. Similarly also in the place of statins as the first line...
Authors: Andrej Dukát, Milan Kriška, P. Sabaka, P. Gavornik, M. Kužma, Juraj Payer
Vildagliptin: experience and prospects
Vildagliptin is one of the modern antidiabetic drugs from the incretin group. It is a dipeptidyl peptidase-4 (DPP-4i) inhibitor, whose effectiveness and safety (including...
A consensual therapeutic recommendation for type 2 diabetes mellitus by the Slovak Diabetes Society (2018)
Type 2 diabetes mellitus is a heterogeneous medical condition involving multiple pathophysiological mechanisms. Its successful treatment requires an individualized approach and...
Authors: Emil Martinka, Vladimír Uličiansky, Marián Mokáň, Ivan Tkáč, Peter Galajda, Silvia Dókušová, Zbynek Schroner
Comprehensive approach in the management of patients with diabesity
Obesity is currently a global epidemic (pandemic) and the most common metabolic disorder affecting not only adults but also children and adolescents worldwide. Together with the...
Management of the patient with diabetes mellitus and hypertension
Diabetes mellitus and hypertension represent important comorbidities, contributing to the high mortality in this patient group. Therefore they are also called as the lethal...
Atrial fibrilation and diabetes mellitus
Atrial fibrillation and diabetes mellitus are both highly prevalent and global public health issues. Importantly patients with diabetes mellitus are at increased risk for stroke...
Pharmacological management of diabetic dyslipidaemia
Cardiovascular diseases are extremely common in type 2 diabetics. This is due to the presence of characteristic atherogenic dyslipidemia, which significantly contributes to...
Fourier Study: Has it brought little or a lot of good? Or has it just failed to reach exaggerated expectations?
The drugs of a novel class of hypolipidemic agents, PCSK9-inhibitors, are now approved for clinical use. In many EU countries, including Slovakia, these drugs are also available...
SubscriptionSubscribe the Journal
The subscription grants you full access to all the articles.
Issue No.: 1 / 2018
- Transcutaneous oxymetry – its contribution to diabetic management | views: 194
- Overinsulinization – the frequent cause of unsatisfactory glycemic control: case reports | views: 175
- Pharmacological management of diabetic dyslipidaemia | views: 171
- Factors conducive to optimal control of type 1 diabetes mellitus in childhood and adolescence | views: 152
- Insulin in the therapeutic scheme for type 2 diabetes mellitus | views: 147